Jules A. Maltz - 01 Jun 2023 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Role
Director
Signature
/s/ Alexandra Cotter Wilkins, Attorney-in-Fact
Issuer symbol
HIMS
Transactions as of
01 Jun 2023
Net transactions value
$0
Form type
4
Filing time
02 Jun 2023, 16:45:39 UTC
Previous filing
17 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HIMS Class A Common Stock Options Exercise +25,659 +123% 46,522 01 Jun 2023 Direct F1
holding HIMS Class A Common Stock 220,401 01 Jun 2023 By Jules Maltz and Kelly Greenwood Fam Tr UA 07/31/2018
holding HIMS Class A Common Stock 1,224 01 Jun 2023 By Institutional Venture Management XV, LLC F2
holding HIMS Class A Common Stock 1,225 01 Jun 2023 By Institutional Venture Management XVI, LLC F3
holding HIMS Class A Common Stock 40,735 01 Jun 2023 By Institutional Venture Partners XV Executive Fund, L.P. F4
holding HIMS Class A Common Stock 7,666,545 01 Jun 2023 By Institutional Venture Partners XV, L.P. F4
holding HIMS Class A Common Stock 7,707,291 01 Jun 2023 By Institutional Venture Partners XVI, L.P. F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HIMS Restricted Stock Unit Options Exercise $0 -25,659 -100% $0.000000* 0 01 Jun 2023 Class A Common Stock 25,659 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Jules A. Maltz is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The RSUs vested on June 1, 2023, the date of the company's 2023 annual stockholder meeting.
F2 Mr. Maltz is a managing director of IVM XV, which is the general partner of Institutional Venture Partners XV Executive Fund, L.P. ("IVP XV Executive Fund") and Institutional Venture Partners XV, L.P. ("IVP XV"), and IVM XVI, which isthe general partner of Institutional Venture Partners XVI, L.P. ("IVP XVI"). Mr. Maltz may be deemed a beneficial owner of the securities held by IVM XV, IVM XVI, IVP XV Executive Fund, IVP XV and IVP XVI, but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein.
F3 Mr. Maltz is a managing director of Institutional Venture Management XV LLC, which is the general partner of Institutional Venture Partners XV Executive Fund, L.P. ("IVP XV Executive Fund") and Institutional Venture Partners XV, L.P. ("IVP XV"), and Institutional Venture Management XVI LLC, which is the general partner of Institutional Venture Partners XVI, L.P. ("IVP XVI"). Mr. Maltz may be deemed a beneficial owner of the securities held by IVP XV Executive Fund, IVP XV and IVP XVI, but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein.
F4 Mr. Maltz is a managing director of IVM XV, which is the general partner of Institutional Venture Partners XV Executive Fund, L.P. ("IVP XV Executive Fund") and Institutional Venture Partners XV, L.P. ("IVP XV"), and IVM XVI, which is the general partner of Institutional Venture Partners XVI, L.P. ("IVP XVI"). Mr. Maltz may be deemed a beneficial owner of the securities held by IVM XV, IVM XVI, IVP XV Executive Fund, IVP XV and IVP XVI, but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein.